Retatrutide (40mg)
£119.99
Triple agonist of GLP-1, GIP, and glucagon receptors. Advanced research compound for metabolic studies.
- RETATRUTIDE-40-ALLUVI
- 12 in stock
1
Product information
About Retatrutide (40mg)
Triple agonist of GLP-1, GIP, and glucagon receptors. Advanced research compound for metabolic studies. | 40mg total | 4 doses of 10mg | Alluvi Healthcare | Research purposes only. Not for human consumption.
Handling and storage
Supplied for laboratory research use only. Store as directed on the vial and handle in line with your own lab’s protocols.